
Recent Hyponatremia Correction Rate Data Is Becoming Harder to Ignore
Apr 20, 2026 - 10:08
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF...
Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy is an episode from Hospital and Internal Medicine Podcast by Gil Porat, M.D., FACP, CPT. The double-blind, randomized phase III EMPEROR-Preserved tr...
This episode belongs to Hospital and Internal Medicine Podcast.
Use the player on this page to stream the episode online.
Published Jan 27, 2022, 11:32 long, audio available.
The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF). Now let us dig a bit more into those headlines.
You can listen to Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy online on Radio and Podcast. Open the player on this page to stream the available audio.
Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy is an episode from Hospital and Internal Medicine Podcast by Gil Porat, M.D., FACP, CPT.
This episode is 11:32 long.
This episode was published on Jan 27, 2022.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Hospital and Internal Medicine Podcast when more episodes are available from the podcast feed.